Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» ONC-392
ONC-392
BioNTech signs deal to co-develop OncoC4's cancer drug
BioNTech signs deal to co-develop OncoC4's cancer drug
Reuters
BioNTech
OncoC4
cancer
oncology
drug development
ONC-392
Flag link:
OncoC4 doses first participant in ovarian cancer therapy trial
OncoC4 doses first participant in ovarian cancer therapy trial
Clinical Trials Arena
OncoC4
clinical trials
ONC-392
Merck
Keytruda
ovarian cancer
platinum-resistant ovarian cancer
Flag link:
